hVIVO (LON:HVO) Stock Price Down 6.8% – Time to Sell?

hVIVO plc (LON:HVO – Get Free Report)’s share price fell 6.8% on Thursday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). 2,518,262 shares changed hands during trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).

hVIVO Stock Performance

The company has a 50 day moving average price of GBX 23.20 and a 200-day moving average price of GBX 26.66. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The company has a market cap of £129.95 million, a P/E ratio of 636.67 and a beta of 0.97.

hVIVO Company Profile

(Get Free Report)

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.

Read More

• Five stocks we like better than hVIVO
• Why Invest in 5G? How to Invest in 5G Stocks  
• Quantum Opportunity: Skywater Technology’s Long-Term Potential
• Dividend Capture Strategy: What You Need to Know
• Nebius Group: The Rising Star in AI Infrastructure
• What is a Low P/E Ratio and What Does it Tell Investors?
• MarketBeat Week in Review – 12/30 – 1/03